Ambar Protein Industries reports FY26 net profit of ₹702.66 lakh

1 min read     Updated on 30 May 2026, 06:45 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Ambar Protein Industries Limited reported a net profit of ₹702.66 lakh for the financial year ended March 31, 2026, on revenue from operations of ₹50,065.59 lakh. The Board approved the audited standalone financial results, re-appointed Rajendra Natverlal Shah & Co. as internal auditor, and approved related party transactions with Ankur Oil Industries.

powered bylight_fuzz_icon
41691144

*this image is generated using AI for illustrative purposes only.

Ambar Protein Industries Limited reported a net profit of ₹702.66 lakh for the financial year ended March 31, 2026, while revenue from operations increased to ₹50,065.59 lakh. The company's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, during a meeting held on May 30, 2026. The statutory auditor, M/s. Fenil P Shah and Associates, issued an audit report with an unmodified opinion on the standalone financial results.

For the quarter ended March 31, 2026, the company recorded a net profit of ₹246.41 lakh on revenue from operations of ₹14,679.97 lakh. Total income for the quarter stood at ₹14,701.83 lakh, while total expenses were ₹14,358.80 lakh. The basic and diluted earnings per share (EPS) for the quarter were reported at ₹4.29 each.

The full-year financial performance showed a total income of ₹50,143.72 lakh against total expenses of ₹49,205.13 lakh. The profit before tax for the year was ₹938.59 lakh, with a total tax expense of ₹235.93 lakh. Basic and diluted EPS for the year were ₹12.22. The company's only business segment is the manufacturing and selling of edible oil.

Financial Results for FY26

Particulars Year Ended 31.03.2026 (₹ in Lacs) Year Ended 31.03.2025 (₹ in Lacs)
Revenue from operations 50,065.59 42,162.30
Total Income 50,143.72 42,246.46
Total Expenses 49,205.13 40,943.36
Profit before tax 938.59 1,303.11
Net Profit 702.66 965.02
Basic EPS (₹) 12.22 16.78

Board Decisions

The Board approved the re-appointment of Rajendra Natverlal Shah & Co. as the internal auditor for FY 2026-27. Additionally, the Board approved related party transactions with Ankur Oil Industries regarding the sale of goods and job work, subject to shareholder approval. The company confirmed that the financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed by the Audit Committee.

Historical Stock Returns for Ambar Protein Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-4.44%-0.05%+8.31%-34.56%-11.57%+2,417.01%

What strategies will Ambar Protein Industries implement to reverse the decline in net profit and profit before tax compared to the previous fiscal year?

How will the company manage the rising total expenses, which grew faster than revenue, to improve profit margins in FY27?

What impact will the approved related party transactions with Ankur Oil Industries have on the company's operational efficiency and revenue streams?

Ambar Protein Industries
View Company Insights
View All News
like15
dislike

Ambar Protein schedules board meet on May 30 for Q4FY26 results

1 min read     Updated on 20 May 2026, 01:45 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Ambar Protein Industries Limited will hold a board meeting on May 30, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The agenda includes reviewing related party transactions with M/s. Ankur Oil Industries. The trading window for insiders has been closed from April 1, 2026, until 48 hours post-result announcement.

powered bylight_fuzz_icon
40810524

*this image is generated using AI for illustrative purposes only.

Ambar Protein Industries Limited has announced that its board of directors will meet on May 30, 2026, to discuss and approve the audited financial results for the quarter and fiscal year ending March 31, 2026. The meeting is scheduled to take place at 03:30 PM at the company's registered office located on the Sarkhej - Bavla Highway in Ahmedabad.

Agenda for the Meeting

The primary focus of the board meeting will be the financial performance of the company for the fourth quarter and the full financial year 2026. Alongside the financial results, the directors will consider specific related party transactions involving M/s. Ankur Oil Industries. The board will also transact other routine business items as listed on the agenda.

Trading Window Closure

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, the trading window for dealing in the company's shares has been closed. This restriction applies to all designated employees and insiders. The closure period commenced on April 1, 2026, and will remain in effect until 48 hours after the financial results information is made generally available to the public.

Meeting Details

The following table summarizes the key details regarding the upcoming board meeting:

Event Details Information
Meeting Date May 30, 2026
Meeting Time 03:30 PM
Venue Registered Office, Sarkhej - Bavla Highway, Ahmedabad
Financial Period Quarter and Year ended March 31, 2026
Trading Window Closure April 1, 2026 onwards

Historical Stock Returns for Ambar Protein Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-4.44%-0.05%+8.31%-34.56%-11.57%+2,417.01%

How might Ambar Protein Industries' FY2026 financial results compare to industry peers in the protein/edible oil sector, and what growth trajectory could investors expect going forward?

What are the potential implications of the related party transactions with M/s. Ankur Oil Industries on Ambar Protein Industries' future profitability and corporate governance standing?

Could the board meeting on May 30, 2026 also serve as a platform to announce dividend declarations or capital allocation strategies for the upcoming fiscal year?

Ambar Protein Industries
View Company Insights
View All News
like17
dislike

More News on Ambar Protein Industries

1 Year Returns:-11.57%